The etanercept biosimilar Brenzys™ has been listed on the PBS for use in adults with severe active rheumatoid arthritis, ankylosing spondylitis, severe psoriatic arthritis, and severe chronic plaque psoriasis.* Marketed by MSD in Australia Brenzys™ is the first biosimilar of Pfizer’s originator drug Enbrel™. While its listing has been welcomed by professional bodies and consumer ...
Updated: Etanercept biosimilar listed on the PBS
By Nicola Garrett
4 Apr 2017